Artificial intelligence is transforming the way we develop new therapies—and we’re just getting started.

The traditional drug discovery process is costly, slow, and riddled with failure. In fact, more than 86% of drug candidates never make it past clinical trials. But AI is rewriting the rules. From early-stage screening to real-time clinical trial optimization, AI is making drug discovery faster, more efficient, and more precise.

In this visual deep dive, we’ve partnered with Technology Networks to bring you a data-packed infographic that reveals how AI is reshaping the future of medicine. Whether you’re exploring target identification or looking to streamline lead optimization, this infographic breaks down the critical ways AI is revolutionizing every step of the process.

AI isn’t just a buzzword—it’s a biotech breakthrough. By bringing speed and precision to drug development, AI is helping scientists get closer to the therapies of tomorrow, today.

Want the full picture?

For more insights on the latest developments in biologics and cell line research, visit Sphere Bio’s Knowledge Hub or explore our cutting-edge solutions for high-throughput screening and single-cell analysis.

This is part of our Editorial Coverage series, highlighting Sphere Bio’s contributions to leading scientific and industry publications. Stay updated on how our technology is shaping the future of biopharmaceutical discovery.